ESC 365 - Aspirin versus no aspirin on top of vitamin K antagonists in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischaemic and bleeding events

ESC Premium Access

Aspirin versus no aspirin on top of vitamin K antagonists in outpatients with stable coronary artery disease and atrial fibrillation: Association with ischaemic and bleeding events

Session: Tailoring antithrombotics according to bleeding risk

Topic: Antithrombotic agents

Speaker: Professor G. Lemesle (Lille, FR)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Professor Gilles Lemesle

Lille University Hospital, Lille (France)

1 presentation

0 follower

4 more presentations in this session

State of the art in tailoring antithrombotics according to bleeding risk.

Speaker: Professor F. Andreotti (Rome, IT)

Combining oral anticoagulants with antiplatelet therapy in patients with non-valvular atrial fibrillation: findings from the GLORIA-AF registry program

Speaker: Professor M. Huisman (Leiden, NL)

Impact of previous exposure to oral anticoagulants on the risk of death or rehospitalization in patients with acute coronary syndrome - analysis according to the anticipated risk of bleeding.

Speaker: Doctor C. Ruivo (Leiria, PT)

Future direction for research in tailoring according to bleeding risk.

Speaker: Professor R. De Caterina (Pisa, IT)

Access the full session

Tailoring antithrombotics according to bleeding risk

Speakers: Professor G. Lemesle, Professor F. Andreotti, Professor M. Huisman, Doctor C. Ruivo, Professor R. De Caterina

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources